Literature DB >> 24591109

Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials.

Feng Chen1, Weibo Cai.   

Abstract

The last decade has witnessed an unprecedented expansion in the design, synthesis and preclinical applications of various multifunctional nanomaterials. Efficient targeting of these nanomaterials to the tumor site is critical for delivering sufficient amount of anti-cancer drugs to suppress tumor growth, while avoiding undesired side effects. Although some nanoparticles could accumulate in the tumor tissue based on the enhanced permeability and retention effect, which may also bind to targets on the tumor cell surface after extravasation from the tumor vasculature, these strategies have many limitations. In this article, we discuss the concept of tumor vasculature targeting and summarize representative examples of in vivo targeted positron emission tomography imaging of various functionalized nanomaterials with different morphology, size and surface chemistry. The concept of targeting tumor vasculature instead of (or in addition to) tumor cells will continue to inspire the design of more advanced nanosystems for efficacious and personalized treatment of cancer in the future.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cancer; molecular imaging; nanomaterials; positron emission tomography (PET); tumor angiogenesis; vasculature targeting

Mesh:

Substances:

Year:  2014        PMID: 24591109      PMCID: PMC4126500          DOI: 10.1002/smll.201303627

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  60 in total

1.  A definition of molecular imaging.

Authors:  David A Mankoff
Journal:  J Nucl Med       Date:  2007-06       Impact factor: 10.057

Review 2.  Theranostic nanoparticles engineered for clinic and pharmaceutics.

Authors:  Xiaowei Ma; Yuliang Zhao; Xing-Jie Liang
Journal:  Acc Chem Res       Date:  2011-07-06       Impact factor: 22.384

3.  Tumor endothelial marker 8 expression in triple-negative breast cancer.

Authors:  Luke G Gutwein; Samer Z Al-Quran; Stephen Fernando; Bradley S Fletcher; Edward M Copeland; Stephen R Grobmyer
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

4.  Positron emission tomography imaging of CD105 expression during tumor angiogenesis.

Authors:  Hao Hong; Yunan Yang; Yin Zhang; Jonathan W Engle; Todd E Barnhart; Robert J Nickles; Bryan R Leigh; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-04       Impact factor: 9.236

5.  In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.

Authors:  Hao Hong; Kai Yang; Yin Zhang; Jonathan W Engle; Liangzhu Feng; Yunan Yang; Tapas R Nayak; Shreya Goel; Jero Bean; Charles P Theuer; Todd E Barnhart; Zhuang Liu; Weibo Cai
Journal:  ACS Nano       Date:  2012-02-16       Impact factor: 15.881

6.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Authors:  Weibo Cai; Dong-Woon Shin; Kai Chen; Olivier Gheysens; Qizhen Cao; Shan X Wang; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

7.  Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation.

Authors:  Bryan Ronain Smith; Paul Kempen; Donna Bouley; Alexander Xu; Zhuang Liu; Nicholas Melosh; Hongjie Dai; Robert Sinclair; Sanjiv Sam Gambhir
Journal:  Nano Lett       Date:  2012-06-11       Impact factor: 11.189

8.  RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors.

Authors:  Zipeng Zhen; Wei Tang; Hongmin Chen; Xin Lin; Trever Todd; Geoffrey Wang; Taku Cowger; Xiaoyuan Chen; Jin Xie
Journal:  ACS Nano       Date:  2013-06-04       Impact factor: 15.881

Review 9.  Human studies of angiogenic gene therapy.

Authors:  Rajesh Gupta; Jörn Tongers; Douglas W Losordo
Journal:  Circ Res       Date:  2009-10-09       Impact factor: 17.367

Review 10.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  22 in total

1.  Long circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging.

Authors:  Cheng Xu; Sixiang Shi; Liangzhu Feng; Feng Chen; Stephen A Graves; Emily B Ehlerding; Shreya Goel; Haiyan Sun; Christopher G England; Robert J Nickles; Zhuang Liu; Taihong Wang; Weibo Cai
Journal:  Nanoscale       Date:  2016-04-25       Impact factor: 7.790

Review 2.  Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

Authors:  Emily B Ehlerding; Piotr Grodzinski; Weibo Cai; Christina H Liu
Journal:  ACS Nano       Date:  2018-03-01       Impact factor: 15.881

3.  General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting.

Authors:  Feng Chen; Shreya Goel; Sixiang Shi; Todd E Barnhart; Xiaoli Lan; Weibo Cai
Journal:  Nano Res       Date:  2018-05-08       Impact factor: 8.897

Review 4.  Theranostic nanoparticles.

Authors:  Feng Chen; Emily B Ehlerding; Weibo Cai
Journal:  J Nucl Med       Date:  2014-11-20       Impact factor: 10.057

5.  VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo.

Authors:  Sixiang Shi; Kai Yang; Hao Hong; Feng Chen; Hector F Valdovinos; Shreya Goel; Todd E Barnhart; Zhuang Liu; Weibo Cai
Journal:  Biomaterials       Date:  2014-11-15       Impact factor: 12.479

6.  Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes.

Authors:  Emily B Ehlerding; Shreya Goel; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-08       Impact factor: 9.236

7.  Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.

Authors:  Joseph P Marshalek; Paul S Sheeran; Pier Ingram; Paul A Dayton; Russell S Witte; Terry O Matsunaga
Journal:  J Control Release       Date:  2016-09-26       Impact factor: 9.776

8.  Intrinsically radiolabeled nanoparticles: an emerging paradigm.

Authors:  Shreya Goel; Feng Chen; Emily B Ehlerding; Weibo Cai
Journal:  Small       Date:  2014-06-30       Impact factor: 13.281

Review 9.  Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy.

Authors:  Anyanee Kamkaew; Feng Chen; Yonghua Zhan; Rebecca L Majewski; Weibo Cai
Journal:  ACS Nano       Date:  2016-04-08       Impact factor: 15.881

10.  In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.

Authors:  Feng Chen; Hao Hong; Shreya Goel; Stephen A Graves; Hakan Orbay; Emily B Ehlerding; Sixiang Shi; Charles P Theuer; Robert J Nickles; Weibo Cai
Journal:  ACS Nano       Date:  2015-04-08       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.